Adaptive Biotechnologies (ADPT on Nasdaq) is making significant advancements in biotechnology, focusing on harnessing the adaptive immune system for diagnosing and treating diseases

  One of their primary areas of development is in T-cell receptor (TCR) therapeutics. They have identified and characterized over 8,000 uniq...